bronopol
TRANSCRIPT
7/23/2019 Bronopol
http://slidepdf.com/reader/full/bronopol 1/3
Bronopol is moderately toxic in acute oral toxicity studies with rats, with a lethal
dose (LD) 50 of 307 milligrams!ilogram (mg!g) for males and 3"# mg!g for
females ($oxicity %ategory &&) ($oxicity %ategory & has the highest toxicity and
%ategory &' the lowest) &n an acute inhalation study on the rat, ronopol was found
to e slightly toxic with an lethal concentration (L%) 50 of 5 mgliter (L) ($oxicity
%ategory &&&)
*esults from an acute dermal toxicity study (rat) suggest that ronopol is highly
toxic y the dermal route ($oxicity %ategory &), with an L% 50 of +" to +0 mg!g
-light to moderate erythema and slight to se.ere edema was noted, and the results
of this study determined that ronopol was a slight to se.ere irritant ($oxicity
%ategory &&) &n a study to determine dermal sensiti/ation potential (ai 112,
guinea pigs), ronopol was determined not to e a s!in sensiti/er &n addition,
ronopol has een shown to e a corrosi.e eye irritation ($oxicity %ategory &)
chronic feedingcarcinogenicity study with rats resulted in high mortality, stomach
lesions, and se.ere reduction in ody weight gain $he unpalataility of ronopolreduced the water inta!e and urine output in a dose4related manner in all treated
groups, which may ha.e aected the results of the study Based on the ao.e
6ndings, the systemic 89L and L89L for oth sexes are 0 mg!gday and "0
mg!gday, respecti.ely &n a chronic dermalcarcinogenicity study, male mice
exhiited moderate reduction in ody weight gain in the high dose group Bronopol
was not determined to e carcinogenic in either study $he 9: 8;ce of :esticide
:rogram<s *eference Dose (*fD):eer *e.iew %ommittee e.aluated the carcinogenic
potential of ronopol and found there to e e.idence of non4carcinogenicity for
humans ased on a lac! of e.idence of cancer eects in acceptale studies &n
addition, ronopol was not mutagenic in four mutagenicity studies=
De.elopmental toxicity studies were conducted using rats and raits $he results
showed marginal to no eects in the rat study and eects only at the high dose
le.el in the rait study &n the study on rats, no de.elopmental eects could e
attriuted to the administration of ronopol, and the highest dose of 10 mg!gday
is considered to e the 89L for oth maternal and de.elopmental toxicity &n the
study on raits, the maternal and de.elopmental 89L and L89L are "0
mg!gday and 10 mg!gday (the highest dose group), respecti.ely $he eects
oser.ed only in the 10 mg!gday group include decreased fetal ody weight in
oth sexes (02), and an increase in fetuses with ma>or external.isceral and
s!eletal anormalities (+2 4 #52)
VI. Determination of Safety for U.S. Population, Infants and
Children Back to Top
Based on the information in this preamble and on the modeled exposure levels that are well-
below any dose level where adverse effects are expected, EPA concludes that there is a
7/23/2019 Bronopol
http://slidepdf.com/reader/full/bronopol 2/3
reasonable certainty of no harm to any population subgroup from aggregate exposure to residues
of bronopol. Accordingly, EPA finds that exempting bronopol from the requirement of a
tolerance will be safe for the general population including infants and children.how citation box
'&& 8ther %onsiderations Bac! to $op
A. Endocrine Disruptors
!"PA requires EPA to develop a screening program to determine whether certain substances,
including all pesticide chemicals #both inert and active ingredients$, %may have an effect in
humans that is similar to an effect produced by a naturally occurring estrogen, or such other
endocrine effect . . . .& EPA has been wor'ing with interested sta'eholders to develop a screening
and testing program as well as a priority setting scheme. As the Agency proceeds with
implementation of this program, further testing of products containing bronopol for endocrine
effects may be required.how citation box
'&&& %onclusions Bac! to $op
(here is sufficient information on bronopol to conduct this assessment. Bronopol has been
shown to have significant dermal acute toxicity, and eye and gastrointestinal irritation, but it is
not a s'in sensiti)er. tudy results indicate that bronopol has moderate acute and chronic oral
toxicity, and slight acute inhalation toxicity. *t is not considered to be carcinogenic. !or
developmental effects, marginal to no effects were reported in the rat study and effects were
observed only at the high dose level in the rabbit study. +eproductive toxicity was observed only
in the high-dose group as evidenced by a slight decrease in the female fertility index during the !
mating.how citation box
Although, bronopol does have toxicity, the small amount that will be permitted for use in
pesticide formulations #./ or less by weight$ is expected to result in no effects of concern for
all endpoints, including residential exposures. (he results from a conservative dietary screening
model show that acute and chronic dietary exposure for all population subgroups are considered
to be not of concern. (he highest dietary exposure estimates from the conservative screening
model are well-below any dose level at which an adverse effect is expected. Bronopol is
expected to have a relatively short half-life upon release into the environment, therefore, its
contribution to drin'ing water is not expected.how citation box
0onsidering the information above, there is a reasonable certainty that no harm to any populationsubgroup will result from aggregate exposure to the pesticide chemical #bronopol$ residue,
including all anticipated dietary exposures and all other exposures for which there is reliable
information. Exemptions from the requirement of a tolerance are established for 1-bromo-1-
nitro-,2-propanediol3 #0A +eg. 4o. 51-5-63$ when used as an inert ingredient in-can
preservative at ./ or less by weight of the total pesticide formulation when applied to
7/23/2019 Bronopol
http://slidepdf.com/reader/full/bronopol 3/3
growing crops or to raw agricultural commodities after harvest under 0!+ 7.8, and when
applied to animals under 0!+ 7.82